- Home
- / Insamo
Insamo
Total Funding
$12 M
Insamo Summary
Company Summary
- Overview
- Insamo is a biotechnology company that develops a drug discovery platform. The platform focuses on discovering membrane-permeable and cyclic peptide drugs.
- Type
- Private
- Status
- Active
- Founded
- 2022
- HQ
- Berkeley, CA, US | view all locations
- Website
- https://insamo.com/
Table of Contents
Key People
Glen McIntyre, COO
Timothy Craven, Co-Founder & CEO
LocationsView all
2 locations detected
Berkeley, CA HQ
United States
2630 Bancroft Way
Chippendale, NSW
Australia
12-16 Chippen Street